Market Research Reports, Inc. has announced the addition of “Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance” research report to their offering. See more at - http://mrr.cm/UmR

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: January 1, 2018
 Number of Pages: 73
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 6,995
Price For Site User License: USD 13,990
Price For Global User License: USD 20,985
Delivery Time: Within 24 Hours (During Working
Days)

3. www.MarketResearchReports.com
About the Report
Antibacterial resistance is currently believed to be
responsible for over 700,000 deaths each year.
As antibiotic resistance increases, due to the
overuse and misuse of antibiotics, the number of
avoidable deaths is expected to increase, with one
study predicting there will be 10 million deaths
caused by bacteria resistant to antibiotics in 2050.

4. www.MarketResearchReports.com
Key Highlights:
There are several techniques being utilized to
combat the spread of antibiotic resistance, which
range from combining antibiotics to increase
efficacy to reducing the use antibiotics in both
humans and livestock.
However, significantly reducing the number of
deaths caused by antibacterial resistance will
require the development of new antibacterials that
target infections caused by the most deadly and
antibiotic resistant bacteria while acting on targets
not currently utilized by marketed products in
order to avoid cross resistance.
Without the development of innovate antibacterial
products the emergence and spread of antibiotic
resistance will not only increase the number of
avoidable deaths caused by the infection itself.

5. www.MarketResearchReports.com
Key Highlights: Continues…
It also has the potential to increase the risks
associated with surgery, while putting additional
pressure on already stretched healthcare
providers, as treating drug-resistant infections is
considerably more expensive than treating drug-
susceptible infections.
This report examines the entire antibacterial
therapy area with a particular focus on four key
indications, methicillin resistant staphylococcus
aureus (MRSA), sepsis, pneumonia and
tuberculosis, which were selected due to their
pipeline size, prevalence and level of unmet need.

6. www.MarketResearchReports.com
Scope:
The antibacterial pipeline is large, with 1,634
products in active development. Does current
pipeline innovation hold the potential to affect the
future antibacterial market?
The four key indications in the antibacterial
pipeline are tuberculosis, pneumonia, MRSA and
sepsis. How does the composition of each
pipeline compare both in terms of first-in-class
and non-first-in-class innovation.
There are 234 first-in-class products in the
antibacterial pipeline. Which of these possess the
greatest potential to improve disease outcome and
be commercially successful, based on their
target?

7. www.MarketResearchReports.com
Scope: Continues…
Analysis of strategic consolidations and deals
revealed a high level of activity between 2006 and
2017.
A significant number of first-in-class products
have been identified with no prior involvement in
deals.
How does deal frequency and value compare
between target families and molecule types, and
which first-in-class programs have not yet been
involved in a licensing or co-development deal?

8. www.MarketResearchReports.com
Reasons to buy:
Appreciate the current clinical and commercial
landscapes by considering disease symptoms,
pathogenesis, etiology, co-morbidities and
complications, epidemiology, diagnosis,
prognosis and treatment options.
Visualize the composition of the antibacterial
therapeutics market in terms of dominant
molecule types and targets, highlighting what the
current unmet needs are and how they can be
addressed.
This knowledge allows a competitive
understanding of gaps in the current market.
Analyze the antibacterial pipeline and stratify by
stage of development, molecule type and
molecular target.

9. www.MarketResearchReports.com
Reasons to buy: Continues…
Assess the therapeutic potential of first-in-class
targets. Using a proprietary matrix, human first-in-
class targets have been assessed and ranked
according to clinical potential.
Promising early-stage targets have been
reviewed in greater detail.
Consider first-in-class pipeline products with no
prior involvement in licensing and co-development
deals, which may represent potential investment
opportunities.

10. www.MarketResearchReports.com
Report Coverage:
1. Executive Summary
2. The Case for Innovation
3. Clinical and Commercial Landscape
4. Assessment of Pipeline Product Innovation
5. Signaling Pathways, and First-in-Class
Molecular Target Integration
6. First-in-Class Target and Pipeline Program
Evaluation
7. Deals and Strategic Consolidations
8. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

11. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter
at:
http://www.marketresearchreports.com/subscribe-to-
newsletter

12. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/UmR
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Mr. Sudeep Chakravarty
Email : info@marketresearchreports.com
Phone: +1-302-703-9904 (USA) +91-8762746600 (India)